Heart failure in women is different than in men; should treatment be different

Key points
- Women with heart failure differ from their male counterparts in a number of ways, including etiology, pattern of cardiac remodeling, and prognosis.
- Heart failure affects nearly 5 million people in the United States, and more than 50% of them are women.
- The risk factors for heart failure are similar in women and men, but the relative risks are different.
- They may even respond differently to medical therapy.
Women with heart failure differ from their male counterparts in a number of ways, including etiology, pattern of cardiac remodeling, and prognosis.
They may even respond differently to medical therapy. But until prospective, sex-specific studies show that we should do otherwise, we recommend that women with heart failure be treated the same as men, according to established guidelines.
Women tend to develop heart failure at an older age and with better left ventricular systolic function compared with men.
Women are more likely than men to have hypertension and diabetes as underlying risk factors for heart failure and are less likely to have coronary artery disease.
However, when they have coronary artery disease, it is a strong risk factor for the development of heart failure.
The morbidity associated with heart failure in women is significant, but the prognosis is better than in men, since women with heart failure generally survive longer.
Current guidelines for heart failure therapy are not sexspecific, since there are no large, prospective, randomized, blinded, sex-specific heart failure therapeutic trials.
RiGHT NOW, WE KNOW more about how heart failure is different in women than whether it should be treated differently.
Studies of heart failure treatment have included mostly men, and the results have been generalized to women even though there are pharmacologic and pathophysiologic differences between the sexes. In fact, most of our current knowledge about treating heart failure in women is based on post hoc analyses.
Until prospective sex-specific studies are performed, however, we recommend following current guidelines and treating women with heart failure the same as we treat men.
WOMEN DEVELOP HEART FAILURE LATER
Heart failure affects nearly 5 million people in the United States, and more than 50% of them are women. Compared with men, women tend to develop heart failure at an older age1 and with better left ventricular systolic function. Heart failure with preserved left ventricular function is also more common in women.
RISK FACTORS ARE SIMILAR, BUT RELATIVE RISKS ARE DIFFERENT
The risk factors for heart failure are similar in women and men, but the relative risks are different.
Below is a discussion of the risk factors for heart failure from the perspective of women, and a brief discussion of peripartum cardiomyopathy.
more
Cleveland Clinic Journal of Medicine, 06/05/07
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsEarly menopause ups heart failure risk, especially for smokers
Women who go through menopause early - at ages 40 to 45 - have a higher rate of heart failure, according to a new study published online today in Menopause, the journal of The North American Menopause Society (NAMS).…
15 May 2014
NewsCardiac screening test may help determine who should take aspirin to prevent heart attack
For over 30 years, aspirin has been known to prevent heart attacks and strokes, but who exactly should take a daily aspirin remains unclear. New research published today in Circulation: Cardiovascular Quality and…
12 May 2014
NewsGenome regions once mislabeled 'junk' linked to heart failure
Large sections of the genome that were once referred to as "junk" DNA have been linked to human heart failure, according to research from Washington University School of Medicine in St. Louis. So-called junk DNA was…





